Search and analyze individual stocks with comprehensive metrics

Prevest Denpro Ltd

PREVESTMedical Equipment & Supplies
463.05+0.00 (+0.00%)
As on 16 Jan 2026, 10:14 amMarket Closed

Fundamental Score

...

Prevest Denpro Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Good

Return on Equity

18.74%
Excellent

Return on Capital Employed

25.25%
Excellent

Operating Profit Margin (5Y)

36.63%
Poor

Dividend Yield

0.23%

Valuation Metrics

Excellent

Price to Earnings

26.18x

Market Capitalization

521.17 (Cr)

Industry P/E

47.87x

Growth Metrics

Average

YoY Quarterly Profit Growth

15.08%
Poor

YoY Quarterly Sales Growth

14.76%
Excellent

Sales Growth (5Y)

22.80%
Poor

EPS Growth (5Y)

-61.33%
Excellent

Profit Growth (5Y)

29.49%

Financial Health

Excellent

Debt to Equity

0.00x

Interest Coverage

N/A
Good

Free Cash Flow (5Y)

26.29 (Cr)

Ownership Structure

Good

Promoter Holding

73.60%
Poor

FII Holding

0.63%
Poor

DII Holding

0.75%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
73.60%
Promoter Holding
521.17 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of PREVEST across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Strong Return on Equity (18.74%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (25.25%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Strong Operating Margins (36.63%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Attractive Valuation (P/E: 26.18 vs Industry: 47.87)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Consistent Growth Track Record (22.80% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Strong Profit Growth Track Record (29.49% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Cash Generation (₹26.29 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (73.60%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

2 factors identified

Weak Earnings Growth (-61.33% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.

Limited Institutional Interest (FII+DII: 1.38%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

Loading Peer Comparison

Finding companies in the Medical Equipment & Supplies sector...

Financial Statements

Comprehensive financial data for Prevest Denpro Ltd

About PREVEST

Business Overview

Prevest Denpro Limited, together with its subsidiaries, develops and manufactures dental materials and equipment in India and internationally. The company offers clinical products, including adhesives, bonding agents, and etchants; auxiliaries; cement and liners; composites; endodontics; finishing and polishing; impression and retraction materials; orthodontics materials and products; temporaries; and tooth whitening products. It also provides laboratory products comprising acrylics, auxiliaries, base plates and waxes, and gypsum products; restorative, prosthetic, and hemostatic materials; preventive care products; and oral care, hygiene and disinfection products, and 3D resins. The company's products are used for endodontics, prosthodontics, periodontics, orthodontics, and restorative and aesthetic dentistry applications, as well as for the fabrication of prosthesis in dental laboratories. Prevest Denpro Limited was incorporated in 1999 and is headquartered in Jammu, India.

Company Details

Symbol:PREVEST
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies

Key Leadership

Mr. Atul Modi
MD & Chairman
Ms. Namrata Modi
CFO & Whole Time Director
Mr. Aman Sadhotra
Company Secretary & Compliance Officer

PREVEST Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)18.74%
Return on Capital Employed25.25%
Operating Profit Margin (5Y)36.63%
Debt to Equity Ratio0.00
Interest Coverage RatioN/A

Growth & Valuation

Sales Growth (5Y)22.80%
Profit Growth (5Y)29.49%
EPS Growth (5Y)-61.33%
YoY Quarterly Profit Growth15.08%
YoY Quarterly Sales Growth14.76%

Frequently Asked Questions

What is the current price of Prevest Denpro Ltd (PREVEST)?

As of 16 Jan 2026, 10:14 am IST, Prevest Denpro Ltd (PREVEST) is currently trading at ₹463.05. The stock has a market capitalization of ₹521.17 (Cr).

Is PREVEST share price Overvalued or Undervalued?

PREVEST is currently trading at a P/E ratio of 26.18x, compared to the industry average of 47.87x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Prevest Denpro Ltd share price?

Key factors influencing PREVEST's price include its quarterly earnings growth (Sales Growth: 14.76%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Prevest Denpro Ltd a good stock for long-term investment?

Prevest Denpro Ltd shows a 5-year Profit Growth of 29.49% and an ROE of 18.74%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.

How does Prevest Denpro Ltd compare with its industry peers?

Prevest Denpro Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare PREVEST's P/E of 26.18x and ROE of 18.74% against the industry averages to determine its competitive standing.

What is the P/E ratio of PREVEST and what does it mean?

PREVEST has a P/E ratio of 26.18x compared to the industry average of 47.87x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹26 for every ₹1 of annual earnings.

How is PREVEST performing according to Bull Run's analysis?

PREVEST has a Bull Run fundamental score of 68.5/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does PREVEST belong to?

PREVEST operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Prevest Denpro Ltd.

What is Return on Equity (ROE) and why is it important for PREVEST?

PREVEST has an ROE of 18.74%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Prevest Denpro Ltd generates profits from shareholders' equity.

How is PREVEST's debt-to-equity ratio and what does it indicate?

PREVEST has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is PREVEST's dividend yield and is it a good dividend stock?

PREVEST offers a dividend yield of 0.23%, which means you receive ₹0.23 annual dividend for every ₹100 invested.

How has PREVEST grown over the past 5 years?

PREVEST has achieved 5-year growth rates of: Sales Growth 22.80%, Profit Growth 29.49%, and EPS Growth -61.33%.

What is the promoter holding in PREVEST and why does it matter?

Promoters hold 73.60% of PREVEST shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is PREVEST's market capitalization category?

PREVEST has a market capitalization of ₹521 crores, placing it in the Small-cap category.

How volatile is PREVEST stock?

PREVEST has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for PREVEST?

PREVEST has a 52-week high of ₹N/A and low of ₹N/A.

What is PREVEST's operating profit margin trend?

PREVEST has a 5-year average Operating Profit Margin (OPM) of 36.63%, indicating the company's operational efficiency.

How is PREVEST's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 14.76% and YoY Profit Growth of 15.08%.

What is the institutional holding pattern in PREVEST?

PREVEST has FII holding of 0.63% and DII holding of 0.75%. Significant institutional holding often suggests professional confidence in the stock.